A new analysis from Avalere Health finds that patients accessing specialty medications - drugs often used to treat life threatening illnesses, such as cancer, rheumatoid arthritis, or multiple sclerosis - through exchange plans are more likely to experience higher out-of-pocket costs in 2015 than in 2014.
Sheahan will lead Avalere Communications, a rapidly growing group within Avalere Health that brings deep substantive and innovative strategic thinking to healthcare communications.
New analysis from Avalere Health finds that the most popular exchange plans* in 2014 increased premiums by 10 percent on average in 2015.
28 States & DC Are Expanding Medicaid Eligibility; Others May Make Decisions to Expand.
New analysis from Avalere Health examines the 2015 Federal Exchange Premium File.
First Time in History of Part D, All PDPs Will Incorporate a Specialty Tier
Avalere-Pope Woodhead collaboration a natural fit to deliver global market services
The following is a list of Avalere Health analyses and reactions to Tuesday's midterm elections.
On October 31, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year (CY) 2015 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) final rule.
On October 31, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year (CY) 2015 Medicare Physician Fee Schedule (MPFS) final rule.
In the Calendar Year (CY) 2015 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule released on October 31, the Centers for Medicare & Medicaid Services (CMS) finalized a 2015 base per treatment rate of $239.43, up slightly from $239.02 in CY 2014.
Avalere Health has identified key issues to monitor during tomorrow's midterm election.
On October 29, Avalere Health and The SCAN Foundation released a roadmap on person-centered care sustainability, offering organizations specific examples of person-centered care models leading towards short and long-term savings.
In at least six states, Medicaid programs could be expanded as a result of the outcome of the 2014 governors' races.
As of October 28, 2014, 28 states and D.C. have decided to expand Medicaid eligibility; more may expand next year.
On October 13, JAMA Internal Medicine published a study on the available clinical validity and clinical utility of pharmacogenomic information included in drug labels.
A new analysis from Avalere Health projects that enrollment of Medicaid and Children's Health Insurance Program (CHIP) beneficiaries in managed care - i.e., state payment of private companies to provide benefits - will increase by 13.5 million individuals from 2013 to 2016.
On Oct. 8, the Centers for Medicare & Medicaid Services (CMS) posted detailed information regarding formulary structures, drug coverage, cost-sharing amounts, and utilization management (UM) trends across standalone Medicare prescription drug plans (PDPs) for the 2015 benefit year.
On Oct. 17, the Centers for Medicare & Medicaid Services (CMS) released their most recent report detailing Medicaid enrollment attributable to the Affordable Care Act (ACA).
Avalere Health announced today that Lindy Hinman will be re-joining the company as senior vice president, leading its Health Plans and Managed Care Practice.
